Copyright
©The Author(s) 2021.
World J Exp Med. Nov 20, 2021; 11(5): 66-78
Published online Nov 20, 2021. doi: 10.5493/wjem.v11.i5.66
Published online Nov 20, 2021. doi: 10.5493/wjem.v11.i5.66
Figure 1 Summary of the interplay of the human immunodeficiency virus- antiretroviral therapy related contributing factors to cardiovascular disease and intermittent fasting potential benefits among People living with human immunodeficiency virus.
Figure 2 Summary of the potential benefits of the direct intermittent fasting pathway among People living with human immunodeficiency virus.
Figure 3 Summary of the potential benefits of the indirect intermittent fasting pathway among People living with human immun
Figure 4 Summary of the direct (black) and indirect (gray) mechanisms of intermittent fasting in cardiovascular disease in People living with human immunodeficiency virus.
- Citation: Gnoni M, Beas R, Raghuram A, Díaz-Pardavé C, Riva-Moscoso A, Príncipe-Meneses FS, Vásquez-Garagatti R. Potential role of intermittent fasting on decreasing cardiovascular disease in human immunodeficiency virus patients receiving antiretroviral therapy. World J Exp Med 2021; 11(5): 66-78
- URL: https://www.wjgnet.com/2220-315x/full/v11/i5/66.htm
- DOI: https://dx.doi.org/10.5493/wjem.v11.i5.66